Patents/Assignees

CSL BEHRING LENGNAU AG

4 patents in portfolio

US12209261utility2025
Media for the Expression of Recombinant Vitamin K-dependent Proteins
0 cites
US11890327utility2024
Truncated Von Willebrand Factor Polypeptides for Extravascular Administration in the Treatment or Prophylaxis of a Blood Coagulation Disorder
0 cites
US11814421utility2023
Truncated Von Willebrand Factor Polypeptides for Treating Hemophilia
0 cites
US11564976utility2023
Methods for Preparing Modified Von Willebrand Factor
0 cites